Treatment of Hepatitis C Virus with Direct Acting Antivirals (DAA) and Ribavirin (RBV) is Associated with Changes in Serum Apolipoprotein and TNF-alpha Levels

被引：0
|
作者：
Golabi, Pegah [2 ]
Sayiner, Mehmet [2 ]
Estep, Michael J. [2 ]
Elsheikh, Elzafir [2 ]
Lam, Brian P. [2 ]
Pham, Huong T. [2 ]
Stepanova, Maria [2 ]
Younossi, Zobair M. [1 ,2 ]
机构：
[1] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1186
引用
收藏
页码：796A / 796A
页数：1
相关论文
共 50 条
  • [41] LONG- TERM PROGNOSIS AFTER DIRECT ACTING ANTIVIRALS TREATMENT WITH HEPATITIS C VIRUS ERADICATION
    Kurosaki, Masayuki
    Tamaki, Nobuharu
    Izumi, Namiki
    HEPATOLOGY, 2023, 78 : S697 - S697
  • [42] Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment
    Wong, Robert J.
    Jain, Mamta K.
    Therapondos, George
    Shiffman, Mitchell L.
    Kshirsagar, Onkar
    Clark, Christopher
    Thamer, Mae
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (09): : 1329 - 1338
  • [43] Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA
    Chhatwal, J.
    Chen, Q.
    Ayer, T.
    Bethea, E. D.
    Kanwal, F.
    Kowdley, K. V.
    Wang, X.
    Roberts, M. S.
    Gordon, S. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 1023 - 1031
  • [44] Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment
    Taramasso, Lucia
    Montanari, Lara
    Di Biagio, Antonio
    AIDS, 2018, 32 (09) : 1202 - 1203
  • [45] TREATMENT OF PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE 3 INFECTION IN THE ERA OF DIRECT ACTING ANTIVIRALS (DAA): DATA FROM THE GERMAN HEPATITIS C-REGISTRY (DHC-R)
    Cornberg, M.
    Buggisch, P.
    Schober, A.
    Schmutz, G.
    Boeker, K. H. W.
    Link, R.
    Christensen, S.
    Buescher, K. -G.
    Pfeiffer-Vornkahl, H.
    Manns, M. P.
    Sarrazin, C.
    Hueppe, D.
    Berg, T.
    Niederau, C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S794 - S794
  • [46] Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals
    Nevola, Riccardo
    Rinaldi, Luca
    Zeni, Letizia
    Sasso, Ferdinando C.
    Pafundi, Pia C.
    Guerrera, Barbara
    Marrone, Aldo
    Giordano, Mauro
    Adinolfi, Luigi E.
    JGH OPEN, 2020, 4 (04): : 713 - 721
  • [47] Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections
    Izhari, Mohammad Asrar
    DIAGNOSTICS, 2023, 13 (19)
  • [48] Liver fibrosis evolution after hepatitis C treatment with direct acting antivirals (DAA) in co-infected patients HCV/HIV
    Mendez, J.
    Videira Santos, F.
    Cipriano, A.
    Soeiro, C.
    Valdoleiros, S.
    Goncalves, C.
    Tavares, A. P.
    Castro, R. Sarmento E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 241 - 241
  • [49] Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals
    Comarmond, Cloe
    Cacoub, Patrice
    Saadoun, David
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [50] LEDIPASVIR (LDV)/SOFOSBUVIR (SOF) TREATMENT OF HEPATITIS C VIRUS (HCV) IS ASSOCIATED WITH REDUCTION OF SERUM APOLIPOPROTEIN LEVELS
    Younossi, Z.
    Elsheikh, E.
    Stepanova, M.
    Gerber, L.
    Nader, F.
    Brainard, D.
    McHutchinson, J. G.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S599 - S599
12345